Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 1294 entries
View as:

Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00705172 Org: User:
Start: 11/30/08 End: 11/30/08 Due: 11/30/09

Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction

Phase: N/A Priority: Normal
NCT ID: NCT00519844 Org: User:
Start: 07/31/05 End: 01/31/06 Due: 01/31/07

The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01836523 Org: User:
Start: 11/30/13 End: 06/30/15 Due: 06/30/16

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT05443191 Org: User:
Start: 10/20/22 End: 04/27/23 Due: 04/27/24

Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01930188 Org: User:
Start: 12/02/13 End: 10/12/15 Due: 10/12/16

A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03479892 Org: User:
Start: 03/13/18 End: 06/04/19 Due: 06/04/20

A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01780272 Org: User:
Start: 01/31/13 End: 09/30/13 Due: 09/30/14

A Survey on Low Blod Sugar Among Insulin-treated Patients With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02306681 Org: User:
Start: 10/30/14 End: 05/14/15 Due: 05/14/16

Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01868555 Org: User:
Start: 12/31/07 End: 02/29/08 Due: 02/28/09

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01992588 Org: User:
Start: 11/30/13 End: 03/31/14 Due: 03/31/15

A Research Study, Looking at How NovoMix® Works in People With Type 2 Diabetes in Local Clinical Practice in Algeria

Phase: N/A Priority: Normal
NCT ID: NCT03862690 Org: User:
Start: 05/28/20 End: 06/28/21 Due: 06/28/22

Growth Response in Girls With Turner Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01734486 Org: User:
Start: 09/23/96 End: 05/21/03 Due: 05/21/04

Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT02877355 Org: User:
Start: 08/22/16 End: 11/24/17 Due: 11/24/18

SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world Data

Phase: N/A Priority: Normal
NCT ID: NCT06769646 Org: User:
Start: 12/02/24 End: 01/06/25 Due: 01/06/26

Observational Prospective Study on Patients Treated With Norditropin®

Phase: N/A Priority: Normal
NCT ID: NCT00960128 Org: User:
Start: 04/01/06 End: 12/31/16 Due: 12/31/17

Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT02938585 Org: User:
Start: 12/12/16 End: 12/12/18 Due: 12/12/19

A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06326047 Org: User:
Start: 03/18/24 End: 10/13/25 Due: 10/13/26

A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9

Phase: N/A Priority: Normal
NCT ID: NCT05723835 Org: User:
Start: 02/01/23 End: 10/29/27 Due: 10/29/28

A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT05306418 Org: User:
Start: 04/04/22 End: 11/13/24 Due: 11/13/25

Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

Phase: N/A Priority: Normal
NCT ID: NCT06574984 Org: User:
Start: 11/10/24 End: 08/01/25 Due: 08/01/26

A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)

Phase: N/A Priority: Normal
NCT ID: NCT03175120 Org: User:
Start: 05/26/17 End: 04/04/19 Due: 04/04/20

Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04998136 Org: User:
Start: 08/15/22 End: 11/20/23 Due: 11/20/24

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT06285071 Org: User:
Start: 08/08/24 End: 04/30/30 Due: 04/30/31

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

Phase: N/A Priority: Normal
NCT ID: NCT06831734 Org: User:
Start: 03/31/25 End: 01/31/31 Due: 01/31/32

Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01364428 Org: User:
Start: 06/30/11 End: 01/31/12 Due: 01/31/13